Skip to contentI
Imunon, Inc.
I
IMNNImunon, Inc. Q4 2019 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$125.00K$125.00Kderived±0.0% vs Q4 2018 Net Income-$3.10M-$3.10MderivedN/M vs Q4 2018 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Imunon, Inc. · CIK 749647 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$4,747,666N/M Operating Cash Flowderived-$5,616,620N/M Free Cash Flowderived-$5,629,333N/M Margins · derivedOperating margin-3798.1%+2.2 pt vs Q4 2018
Net margin-2482.2%
ended Dec 31, 2019 · filed Mar 25, 2020 · 85 d after period end